Please login to the form below

Not currently logged in
Email:
Password:

Merck

This page shows the latest Merck news and features for those working in and with pharma, biotech and healthcare.

AZ, Merck’s Lynparza scores market-expanding clinical success

AZ, Merck’s Lynparza scores market-expanding clinical success

Positive phase 3 findings in ovarian cancer. Adding AstraZeneca and Merck’s Lynparza (olaparib) to Roche’s Avastin (bevacizumab) has improved outcomes in advanced ovarian cancer patients in a phase ... That approval and clearances in other

Latest news

More from news
Approximately 361 fully matching, plus 1,290 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 9 fully matching, plus 128 partially matching documents found.

Latest appointments

More from appointments
Approximately 37 fully matching, plus 138 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics